Literature DB >> 180219

Measurement of two plasma triglyceride lipases by an immunochemical method: studies in patients with hypertriglyceridemia.

H Greten, R DeGrella, G Klose, W Rascher, J L de Gennes, E Gjone.   

Abstract

Postheparin plasma lipolytic activity consists of two hydrolytic activities, hepatic triglyceride lipase and lipoprotein lipase. These two enzymes were separated and partially purified by means of ammonium sulfate precipitation and affinity chromatography using Sepharose with covalently linked heparin and concanavalin A, respectively. Antibodies were produced against hepatic triglyceride lipase and they did not cross react with lipoprotein lipase. Optimal conditions for selective precipitation of hepatic lipase and specific measurement of these two lipases were investigated. This method was applied to the study of 15 patients with hypertriglyceridemia and 8 patients with familial lecithin-cholesterol-acyltransferase deficiency of whom 6 also had a marked elevated plasma triglyceride concentration. All patients had normal values of hepatic plasma lipase. All 8 patients with Type I and 2 of 4 patients with Type V hyperlipoproteinemia had lipoprotein lipase activities that were markedly reduced. The patients with Type III hyperlipoproteinemia and all 8 patients with lecithin-cholesterol-acyltransferase deficiency also had normal lipoprotein lipase values. These studies emphasize the necessity for differentiating between triglyceride lipase activity of hepatic and extrahepatic origin in evaluating patients with impaired triglyceride metabolism.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 180219

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  10 in total

1.  [Coronary heart disease in patients with primary type V hyperlipoproteinemia (author's transl)].

Authors:  G Middelhoff; R Mordasini; H Zebe; H Greten
Journal:  Klin Wochenschr       Date:  1978-05-01

2.  Abnormal low density lipoproteins in children with familial hypercholesterolemia--effect of polyanion exchange resins.

Authors:  R Mordasini; F Twelsiek; P Oster; B Schellenberg; H Raetzer; C C Heuck; G Schlierf
Journal:  Klin Wochenschr       Date:  1978-08-15

3.  Release of LPL activity after intravenous injection of a low molecular weight heparin.

Authors:  J Etienne; F Millot; R Pieron; P Laruelle
Journal:  Br J Clin Pharmacol       Date:  1983-12       Impact factor: 4.335

Review 4.  Serum lipoproteins during treatment with antihypertensive drugs.

Authors:  P Weidmann; C Ferrier; H Saxenhofer; D E Uehlinger; B N Trost
Journal:  Drugs       Date:  1988       Impact factor: 9.546

5.  Familial chylomicronemia (type I hyperlipoproteinemia) due to a single missense mutation in the lipoprotein lipase gene.

Authors:  D Ameis; J Kobayashi; R C Davis; O Ben-Zeev; M J Malloy; J P Kane; G Lee; H Wong; R J Havel; M C Schotz
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

6.  Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients.

Authors:  G Baggio; E Manzato; C Gabelli; R Fellin; S Martini; G B Enzi; F Verlato; M R Baiocchi; D L Sprecher; M L Kashyap
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

Review 7.  Lipase deficiencies.

Authors:  H Greten; F U Beil
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

8.  [Secondary hyperlipoproteinemia induced by diuretic therapy (author's transl)].

Authors:  R Mordasini; Z Glück; P Weidmann; G Keusch; A Meyer; W Riesen
Journal:  Klin Wochenschr       Date:  1980-04-01

9.  Increased serum phospholipids in epileptic children treated with phenobarbitone.

Authors:  L Pavone; G Klose; F Mollica; M La Rosa; H Greten
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-01       Impact factor: 10.154

10.  Using Synthetic ApoC-II Peptides and nAngptl4 Fragments to Measure Lipoprotein Lipase Activity in Radiometric and Fluorescent Assays.

Authors:  Dean Oldham; Hong Wang; Juliet Mullen; Emma Lietzke; Kayla Sprenger; Philip Reigan; Robert H Eckel; Kimberley D Bruce
Journal:  Front Cardiovasc Med       Date:  2022-07-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.